Here are the Form 4 insider transactions from Sunshine Biopharma Inc. warrant (SBFMW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SBFMW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SBFMW filings page.
NATAN DAVID reported acquisition or exercise transactions in this Form 4 filing.
Sunshine Biopharma Inc. director Natan David received a stock award of 58,300 shares of common stock on August 7, 2026. The award was granted at a stated price of $0.00 per share and increased his directly held position to 68,300 common shares following the transaction. A footnote clarifies that this represents a stock award to the reporting person.
NATAN DAVID reported acquisition or exercise transactions in this Form 4 filing.
Sunshine Biopharma Inc. director Natan David received a stock award of 100,000 shares of Common Stock. The shares were granted at a price of $0.00 per share as compensation, not through an open-market purchase. Following this grant, he directly holds 100,000 shares.